IGM Biosciences, Inc.

IGM Biosciences, Inc. - Current Ratioverified

IGMS

Price:

$1.27

Market Cap:

$77.50M

IGM Biosciences, Inc. operates as a biotechnology firm dedicated to advancing Immunoglobulin M (IgM) antibodies. These novel therapeutic agents are being developed for a broad spectrum of conditions, including various cancers, infectious ailments, and autoimmune and inflammatory disorders. The company's most advanced experimental treatment is IGM-2323, a bispecific IgM antibody. This candidate is currently in Phase 2 clinical trials, evaluating its efficacy for patients diagnosed with relapsed or refractory B cell Non-Hodgkin's lymphoma (NHL). In addition to its lead program, IGM Biosciences maintains an active pipeline of other IgM antibodies. IGM-8444, an IgM antibody, is presently undergo...[Read more]

Industry

Biotechnology

IPO Date

2019-09-18

Stock Exchange

NASDAQ

Ticker

IGMS

The Current Ratio as of June 2026 (TTM) for IGM Biosciences, Inc. (IGMS) is 17.66

According to IGM Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 17.66. This represents a change of 109.35% compared to the average of 8.43 of the last 4 quarters.

IGM Biosciences, Inc. (IGMS) Historical Current Ratio (quarterly & annually)

How has IGMS Current Ratio performed in the past?

The mean historical Current Ratio of IGM Biosciences, Inc. over the last ten years is 10.05. The current 17.66 Current Ratio has changed 17.46% with respect to the historical average. Over the past ten years (40 quarters), IGMS's Current Ratio was at its highest in in the September 2019 quarter at 38.62. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

10.05

Median

8.42

Minimum

0.27

Maximum

26.04

IGM Biosciences, Inc. (IGMS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of IGM Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 9.52%

Maximum Annual Current Ratio = 26.04

Minimum Annual Increase = -59.97%

Minimum Annual Current Ratio = 0.27

Quarterly (TTM)
Annual
YearCurrent RatioChange
20245.14-37.13%
20238.18-16.60%
20229.8113.21%
20218.67-59.97%
202021.65-16.85%
201926.049.52%
20180.27-59.66%

IGM Biosciences, Inc. (IGMS) Average Current Ratio

How has IGMS Current Ratio performed in the past?

The current Current Ratio of IGM Biosciences, Inc. (IGMS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

7.71

5-year avg

10.69

10-year avg

10.05

IGM Biosciences, Inc. (IGMS) Current Ratio vs. Peers

How is IGMS’s Current Ratio compared to its peers?

IGM Biosciences, Inc.’s Current Ratio is greater than Jade Biosciences, Inc. (14.29), greater than Quince Therapeutics, Inc. (2.92), greater than Berkeley Lights, Inc. (3.89), greater than Surface Oncology, Inc. (7.94), greater than Landos Biopharma, Inc. (6.09), greater than Insight Molecular Diagnostics Inc. (2.54), greater than Reneo Pharmaceuticals, Inc. (13.78), greater than Achilles Therapeutics plc (8.57), greater than Heat Biologics, Inc. (0.00), greater than Sigilon Therapeutics, Inc. (2.40),

Build a custom stock screener for IGM Biosciences, Inc. (IGMS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IGM Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IGM Biosciences, Inc. (IGMS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IGM Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is IGM Biosciences, Inc.'s Current Ratio?

How is the Current Ratio calculated for IGM Biosciences, Inc. (IGMS)?

What is the highest Current Ratio for IGM Biosciences, Inc. (IGMS)?

What is the 3-year average Current Ratio for IGM Biosciences, Inc. (IGMS)?

What is the 5-year average Current Ratio for IGM Biosciences, Inc. (IGMS)?

How does the current Current Ratio for IGM Biosciences, Inc. (IGMS) compare to its historical average?